8-41661730-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000524227.5(ANK1):​n.3084A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.768 in 1,602,982 control chromosomes in the GnomAD database, including 474,019 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45020 hom., cov: 31)
Exomes 𝑓: 0.77 ( 428999 hom. )

Consequence

ANK1
ENST00000524227.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.142

Publications

124 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 8-41661730-T-C is Benign according to our data. Variant chr8-41661730-T-C is described in ClinVar as Benign. ClinVar VariationId is 1262189.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.85 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK1NM_000037.4 linkc.5544+146A>G intron_variant Intron 41 of 42 ENST00000289734.13 NP_000028.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK1ENST00000289734.13 linkc.5544+146A>G intron_variant Intron 41 of 42 1 NM_000037.4 ENSP00000289734.8

Frequencies

GnomAD3 genomes
AF:
0.769
AC:
116821
AN:
151990
Hom.:
44969
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.776
Gnomad AMI
AF:
0.626
Gnomad AMR
AF:
0.748
Gnomad ASJ
AF:
0.706
Gnomad EAS
AF:
0.871
Gnomad SAS
AF:
0.803
Gnomad FIN
AF:
0.798
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.760
Gnomad OTH
AF:
0.749
GnomAD2 exomes
AF:
0.783
AC:
191940
AN:
245252
AF XY:
0.781
show subpopulations
Gnomad AFR exome
AF:
0.774
Gnomad AMR exome
AF:
0.810
Gnomad ASJ exome
AF:
0.710
Gnomad EAS exome
AF:
0.870
Gnomad FIN exome
AF:
0.791
Gnomad NFE exome
AF:
0.761
Gnomad OTH exome
AF:
0.776
GnomAD4 exome
AF:
0.768
AC:
1114432
AN:
1450876
Hom.:
428999
Cov.:
46
AF XY:
0.768
AC XY:
554815
AN XY:
722458
show subpopulations
African (AFR)
AF:
0.780
AC:
25986
AN:
33336
American (AMR)
AF:
0.805
AC:
35976
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.711
AC:
18554
AN:
26108
East Asian (EAS)
AF:
0.863
AC:
34220
AN:
39674
South Asian (SAS)
AF:
0.800
AC:
68924
AN:
86104
European-Finnish (FIN)
AF:
0.795
AC:
38099
AN:
47908
Middle Eastern (MID)
AF:
0.719
AC:
4140
AN:
5756
European-Non Finnish (NFE)
AF:
0.761
AC:
842076
AN:
1107114
Other (OTH)
AF:
0.772
AC:
46457
AN:
60162
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
16022
32044
48066
64088
80110
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20336
40672
61008
81344
101680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.769
AC:
116929
AN:
152106
Hom.:
45020
Cov.:
31
AF XY:
0.769
AC XY:
57190
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.777
AC:
32221
AN:
41490
American (AMR)
AF:
0.748
AC:
11437
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.706
AC:
2449
AN:
3468
East Asian (EAS)
AF:
0.871
AC:
4489
AN:
5154
South Asian (SAS)
AF:
0.802
AC:
3864
AN:
4818
European-Finnish (FIN)
AF:
0.798
AC:
8462
AN:
10600
Middle Eastern (MID)
AF:
0.701
AC:
206
AN:
294
European-Non Finnish (NFE)
AF:
0.760
AC:
51647
AN:
67976
Other (OTH)
AF:
0.752
AC:
1586
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1431
2862
4292
5723
7154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
864
1728
2592
3456
4320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.760
Hom.:
175660
Bravo
AF:
0.764
Asia WGS
AF:
0.865
AC:
3010
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.19
DANN
Benign
0.37
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs516946; hg19: chr8-41519248; API